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ABSTRACT 
The synthesis of a novel microemulsion system composed 
a fluorinated oil CgF17
-cHz-CH=CH-C4
Hg with a biocompatible
drogenated surfactant, Montanox 80, is described. 
of 
hy-
Investigation of the solubility of oxygen in these microe­
mulsions showed that they absoi-bed more oxygen than Fluosol-DA, 
currently used as an oxygen transporter in biological systems. 
Oxygen absorption was comparable to that of blood. 
Light scattering studies showed that these systems are com­
posed of small-sized aggregates which should, in principle, be 
compatible with blood. The toxicity of the oil c8F17
-cH
2
-CH=CH­
c4H9 was tested after intraperitoneal injection in rats. No 
toxic effects were observed at doses up to 5 g/kg. 
This study opens new perspectives for the development of 
oxygen-transporting compounds for biomedical applications. 
INTRODUCTION 
The supply of human blood for transfusion and other medi­
cal applications is now faced with new exigencies of biocompati­
bility and sterility, as well as those inherent in the econo­
mics of the collection and storage of samples. Recent concern 
with AIDS bas highlighted the well recognized problem of viral 
contamination of blood,especially that due ta viral hepatitis. 
The choice of a synthetic blood substitute depends to a 
large extent on the particular requirement : 
1) conservation of blood volume can be achieved using solu­
tions of plasma expanders 
2) preservation of ionic balance, for which solutions of
electrolytes are often adequate 
3) transport and distribution of oxygen, and elimination
of carbon dioxide; 
The third function is a more difficult but nonetheless vi­
tal requirement, and forms the subject of this report. 
Blood is a complex liquid containing a large number of com­
ponents serving different functions, of which the most impor­
tant is the dissolution of respiratory gases. Various formula­
tions can be envisaged which satisfy
: 
a number of these require­
ments, although in each case gas exchange must not be iffipaired. 
This latter consideration is so important that gas exchange 
needs to be optimized even at the expense of other capacities 
which can usually be provided by additional components of the 
mixture. 
Respiratory gases can be dissolved in 
1) artifical solutions of hemoglobin
2) solutions of fluorocarbons
Commercially available preparations are in fact based on 
the latter approacb. Perfluorinated derivatives combined with a 
suitable oncotic agent are currently used as blood substitutes. 
Emulsions of perfluorinated compounds have now been tested in 
several hundreds of subjects throughout the world (1-3). 
The essential qualities of fluorocarbons (1,4,5) are 
high capacity to dissolve gases, e-specially oxygen and carbon 
dioxide 
low toxicity resulting from the rapid elimination of the unrne­
tabolized substance from the organism. 
The capacity to dissolve gases is explained by the lack of 
structure of perfluorinaged liquids. They appear to contain ca-
vities. whLch can trap oxygen and carbon diàxide. llowever, 
fluorirtated compounds cannot be used in the pure state, 
the.y need to be formulat:ed as emulsion·s. A sùspension of 
per� 
and 
fine 
particles of fluorocarbon, c.an l)e pt'oduced with the aid of a sui­
table surfactant. 
At present, the cqmmercially- available systems of this ty­
pe are based on Fl1J,O$:Ol DA (an emulsion of perfl_uorodecalin and 
Pluronic F 68:th� l�tter is a copolymer of ethylene and propyle­
ne oxide with a_ molecular weight of 8,350) (2,3). However, thé­
se emulsions lack long t·erm stability, and must be kept refrige­
rated. 
One way round this probl.em is to use microemulsions. They 
have the tri�le advantage of forming spontaneously, remaining 
stable for months or years, and have a range of particle sizes 
which are, compatible with blood. 
How�ver, the formation of microemulsions (like emulsions) 
cornes UJ?:, against problems due to the structure of the perfluori­
nated derivatives themselves. A microemulsion contains three es­
senti�l compori.ent-s (6) : water - surfactant - oil (in this ca­
se a perfluorill.ated c"Ompound). 
The intrinsic hydrophobicity of perfluorinated deriVati­
ves h:i:.rtders microemulsification, due to the phenomenon of segre­
gation between perhydrogenated and perfluorinated chains (i;à). 
Attempts to make these two components mutually compatible ban 
be. div,ided into two main strategies, based on 
i) structural modification of the perfluorinated derivatives, or
ii) selection of the surfactant
For the completely fluorinated compounds, various structu­
res have been tested, including amines, ethers, cyclanes, ole­
fins, etc ... The various studies have shown that the presence 
of a functional group or heteroatom generally leads to slower 
elimination from the organism with a corresponding increase in 
toxicity. This is particularly marked for the amines. The best 
, 
derfv�--tives tbus appear to be represented by. alkanes, cyclanes 
or :.01€.fins (1) • 
The structure of the ·surfactant is also crucial for produc­
tion of suitable microemulsions. Much research is devoted to 
this aspect, especially on the synthesis of surfactants which 
are compatible with perfluorinated alkanes and alkenes lacking 
heteroatoms. 
In view of the problems due to segregation between hydro­
carbon and·perfluorinated chains, reSear-ch bas concentrated on 
perfluorinated surfactants (5,9). 
However, amphiphilic molecules of this type will inevita­
bly present the same disadvantages as the perfluorinated oils. 
In all cases, they are compounds with a polar head (ionic or 
not) and a perfluorinated tail. These surfactants are elimina­
ted slowly from the organism, often being degraded to taxie 
fluoride ions. Much effort is now being put into the develop­
ment of non-toxic fluorinated surfactants. This approach can be 
summarized as ·: 
The ·development of biocompatible fluorinated surfactants 
ta microemulsify perfluorinated oils. 
In view of thè above mentioned considerations, we felt 
that this approach was fraught with difficulties, and we opted 
for an approach which can be summàrized as : 
The adaptation of the oil to a known bioCompatible surfac­
tant. This is effectively the converse of the first approach. 
At present, only hydrogenated non-ionic surfactants (ampho­
teric) have been found to be biocompatible. We thus decided to 
synthesize and test mix.ed oils sufficiently fluorinated to dis­
solve gas and be eliminated rapidly, but sufficiently hydrogena­
ted to enable them to be microemulsified using biocompatible hy­
drogenated sur.factants. 
 METHODS AND RESULTS 
SyntheSis of mixed oils 
The mixed oils synthesized were of general formula RF-CH2-
CH=CH-RH.A rnethod for synthesizing compounds of this type deve­
loped in this laboratory enabled the balance between the fluori­
nated and hydrogenated parts to be altered at will(l0,11) : 
(C6H5)3P + RpCH2cH2I ----- (C6Hs)3P
+CH2CH2Rp, 1-
� Rp-CH2-CH-CH-RH + (C6H5)P-O
(Rp - C2F5, C4F9, C6Fl3• CsF17, C10F21)
From the various compounds synthesized, the mixed oil 
CaF17CH2-CH=CH-C4H9 produced in 74% yield was tested. This com­
pound was found to be a good gas solvent. Determination of oxy­
gen solubility using the Clark electrode showed that it dissol­
ved 43 ml of oxygen per 100 ml. This is comparable to that of F­
decalin (the oil employed in Fluosol DA). 
Microemulsification of the mixed oil c8F17-CH2-CH=CH-C4H9
Various hydrogenated surfactants were tested in order to 
produce rnicroemulsions with this oil. We optimized an aqueous 
system with c8r17-cH2-CH=CH-C4H9 as oil, and the biocompatible
surfactant, Montanox 80 (see Fig_. 1). This surfactant is used 
in the formulation of vaccines by the Institut Pasteur (Paris, 
France) (12). 
The diagram in Figure 1 shows the microernulsion zone at 
37°C (body temperature). The rnicroemulsions are of the oil-in­
water type, which are well suited for use as blood substitutes, 
since they are readily diluted in blood after intravenous admi-
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Fig. 1 .- Phase dia
gram of the system
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ontanox 80 - c8F17-CH2
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 Properties of the microemulsions 
Measurement of viscosity and light scattering at 37 ° C de­
monstrated that the microemulsions were of the oil-in-water ty­
pe, and were composed of small-sized aggregates (mean diaw.. 50-
60 A). Aggregates of this size do not, in principle, favor for� 
mation of emboli after injection into the general circulation. 
The values of viscosity, and oxygen solubility measured 
with the Clark electrode are presented in Table I. 
DISCUSSION 
All the microemulsions tested dissolved more 
FLuosol DA (11 ml 02/100 ml). Oxygen sol_ubility was 
to that of blood (20,6 ml 02;100 ml).
oxygen thàn 
comµarable 
It should be emphasized that the theoretical values 'of oxy-
gen solubility (given the amount of oil in the microèffiulsion) 
are much lower than the measured values. The excess sol,ubility 
was around 500%, This would tend to indicate that the structu­
re of the microemulsions (existence of micellar cages) increa­
ses their capacity to dissolve gas. This phenomenon bas been ob­
served, although to a lesser extent (around 200%) ,for perhydro­
genated oils (13). It should also be noted that the presence of 
a fluorinated oil is required to observe this phe'nomenon of so­
lubilization. Corresponding micellar solutions (without oil) on­
ly took up small amounts of oxygen (around 6 ml/100 ml) �imi­
lar to that observed for water (3 ml/100 ml). 
Preliminary toxicological studies in the rat after inttape­
ritoneal administration have demonstrated the lack of toxicity 
of these systems (12). Further trials are in progress using in-
travenous administration. 
'N' 
Table I - Froperties of the microemulsion system 
C18F17-CH2-CH-CH-C4H9 - water - Montanox 80
Microemulsion 
A (16% oil) 
B (9% oil) 
C (7% oil) 
Oxygen solubility 
(ml/lOOml) 
32 
21 
9 
Viscosity 
(Cp) 
1. 0
0.9
1.1
Agregate diam. 
(A) 
130 
87 
72 
Microemulsion a was used for these experiments. It is a 
good gas solvent, and it could be readily formulated to be com­
patible with blood by the addition of salts. No hem?lysis has 
been observed in the use of these formulations. 
These results demonstrate the feasibility of production of 
microemulsions using fluorinated oils and hydrogenated, biocom­
patible surfactants. Such systems could be employed as blood 
substitutes. An immedtate application WQuld be in the formula­
tion of culture media. 
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